Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

The compound 4c effectively inhibits the enzyme linked to hair loss.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Compound 15a was effective in inhibiting 5α-reductase.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

A new gene mutation causes vitamin D resistance and hair loss in two unrelated girls.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

The new compound may be a safer alternative to finasteride for prostate protection.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

The treatment helped promote hair growth in men with androgenetic alopecia.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.